title: Effect of eplerenone on insulin action in essential hypertension: a randomised, controlled, crossover study.
abstract: An association exists between hyperaldosteronism, hypertension and impaired insulin action. Eplerenone is a selective mineralocorticoid receptor antagonist; however, little is known about its effects on insulin action. The aim of this study was to determine the effect of eplerenone on insulin action in hypertensive adults, using the hyperinsulinaemic euglycaemic clamp. A randomised, controlled, double-blind, crossover design was employed. After a 6-week washout period, hypertensive, non-diabetic patients were treated with either eplerenone 25 mg twice daily or doxazosin 2 mg twice daily for 12 weeks. After each treatment period, insulin action was assessed by a hyperinsulinaemic euglycaemic clamp, with isotope dilution methodology. After washout, treatment groups were crossed over. Fifteen patients completed the study. There were no differences in fasting glucose, or fasting insulin between treatment with eplerenone or doxazosin. The measure of overall insulin sensitivity, exogenous glucose infusion rates during the last 30 min of the clamp, was similar with both treatments; 23.4 (3.9) μmol kg(-1) min(-1) after eplerenone and 23.3 (3.6) μmol kg(-1) min(-1) after doxazosin (P=0.83). Isotopically determined fasting endogenous glucose production rates were similar after both treatments (eplerenone 9.4 (0.6) μmol kg(-1) min(-1) vs doxazosin 10.6 (0.7) μmol kg(-1) min(-1)). There was a trend for lower endogenous glucose production rates during hyperinsulinaemia following eplerenone compared with doxazosin (2.0 (0.8) μmol kg(-1) min(-1) vs 4.1 (0.9) μmol kg(-1) min(-1)). There was no difference in insulin stimulated peripheral glucose utilisation rates after treatment with eplerenone or doxazosin (25.4 (3.6) μmol kg(-1) min(-1) vs 27.0 (3.9) μmol kg(-1) min(-1)). This study gives reassuring evidence of the neutral effect of eplerenone on insulin action in hypertensive, non-diabetic patients.
authors.affiliation: Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, UK.
authors.forename: E M
authors.initials: EM
authors.lastname: McMurray
authors.affiliation: Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, UK.
authors.forename: I R
authors.initials: IR
authors.lastname: Wallace
authors.affiliation: Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, UK.
authors.forename: C
authors.initials: C
authors.lastname: Ennis
authors.affiliation: Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, UK.
authors.forename: S J
authors.initials: SJ
authors.lastname: Hunter
authors.affiliation: Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, UK.
authors.forename: A B
authors.initials: AB
authors.lastname: Atkinson
authors.affiliation: Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, UK.
authors.forename: P M
authors.initials: PM
authors.lastname: Bell
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D018592:Cross-Over Studies; D004311:Double-Blind Method; D000077545:Eplerenone; D000075222:Essential Hypertension; D005260:Female; D006801:Humans; D006973:Hypertension / Q000378:metabolism*; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology*; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D001786:Blood Glucose; D007328:Insulin; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone
references.citation: Diabetologia. 2008 May;51(5):762-8
references.pmid: 18347776
references.citation: BMJ. 1994 Jul 23;309(6949):226-30
references.pmid: 7818648
references.citation: N Engl J Med. 2003 Apr 3;348(14):1309-21
references.pmid: 12668699
references.citation: Diabetes Care. 2005 Sep;28(9):2106-12
references.pmid: 16123474
references.citation: Diabetologia. 2006 Dec;49(12):3009-16
references.pmid: 17019594
references.citation: J Clin Endocrinol Metab. 2007 Nov;92(11):4472-5
references.pmid: 17726083
references.citation: Am J Physiol. 1956 Sep;187(1):15-24
references.pmid: 13362583
references.citation: J Clin Endocrinol Metab. 2000 May;85(5):1882-9
references.pmid: 10843169
references.citation: J Hypertens. 1998 Nov;16(11):1651-7
references.pmid: 9856366
references.citation: Br J Clin Pharmacol. 1979 Jul;8(1):7-20
references.pmid: 552299
references.citation: J Clin Endocrinol Metab. 2010 Apr;95(4):1986-90
references.pmid: 20130077
references.citation: N Engl J Med. 2000 Mar 30;342(13):905-12
references.pmid: 10738048
references.citation: Diabetes Care. 2003 Jan;26 Suppl 1:S5-20
references.pmid: 12502614
references.citation: Clin Endocrinol (Oxf). 2007 May;66(5):607-18
references.pmid: 17492946
references.citation: Trends Endocrinol Metab. 2005 Apr;16(3):120-6
references.pmid: 15808810
references.citation: Diabetologia. 1995 Jul;38(7):853-9
references.pmid: 7556989
references.citation: Circulation. 2008 Apr 29;117(17):2253-61
references.pmid: 18427128
references.citation: N Engl J Med. 1999 Sep 2;341(10):709-17
references.pmid: 10471456
references.citation: Adv Ther. 2011 Aug;28(8):698-706
references.pmid: 21744143
references.citation: Diabetologia. 2004 Oct;47(10):1687-94
references.pmid: 15365622
references.citation: Am J Physiol. 1979 Sep;237(3):E214-23
references.pmid: 382871
references.citation: Hypertension. 2007 Apr;49(4):839-45
references.pmid: 17309946
references.citation: N Engl J Med. 2011 Jan 6;364(1):11-21
references.pmid: 21073363
references.citation: J Hypertens. 1999 Mar;17(3):439-45
references.pmid: 10100083
references.citation: Am Heart J. 2010 Nov;160(5):915-21
references.pmid: 21095280
references.citation: Metabolism. 2003 Sep;52(9):1147-52
references.pmid: 14506621
references.citation: Eur J Heart Fail. 2012 Aug;14(8):909-15
references.pmid: 22611047
references.citation: J Am Coll Cardiol. 2005 Apr 19;45(8):1243-8
references.pmid: 15837256
references.citation: Exp Clin Endocrinol Diabetes. 2000;108(1):21-5
references.pmid: 10768828
references.citation: Diabetes. 1963 Jan-Feb;12:16-30
references.pmid: 14025711
references.citation: Diabetologia. 1990 Nov;33(11):681-7
references.pmid: 2076800
references.citation: J Clin Endocrinol Metab. 2006 Sep;91(9):3457-63
references.pmid: 16822818